IBDEI2TH ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,44931,1,4,0)
 ;;=4^C4A.72
 ;;^UTILITY(U,$J,358.3,44931,2)
 ;;=^5001156
 ;;^UTILITY(U,$J,358.3,44932,0)
 ;;=C4A.62^^170^2241^79
 ;;^UTILITY(U,$J,358.3,44932,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44932,1,3,0)
 ;;=3^Merkle Cell CA,Left Upper Limb,Incl Shoulder
 ;;^UTILITY(U,$J,358.3,44932,1,4,0)
 ;;=4^C4A.62
 ;;^UTILITY(U,$J,358.3,44932,2)
 ;;=^5001153
 ;;^UTILITY(U,$J,358.3,44933,0)
 ;;=C4A.71^^170^2241^86
 ;;^UTILITY(U,$J,358.3,44933,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44933,1,3,0)
 ;;=3^Merkle Cell CA,Right Lower Limb,Incl Hip
 ;;^UTILITY(U,$J,358.3,44933,1,4,0)
 ;;=4^C4A.71
 ;;^UTILITY(U,$J,358.3,44933,2)
 ;;=^5001155
 ;;^UTILITY(U,$J,358.3,44934,0)
 ;;=C4A.61^^170^2241^87
 ;;^UTILITY(U,$J,358.3,44934,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44934,1,3,0)
 ;;=3^Merkle Cell CA,Right Upper Limb,Incl Shoulder
 ;;^UTILITY(U,$J,358.3,44934,1,4,0)
 ;;=4^C4A.61
 ;;^UTILITY(U,$J,358.3,44934,2)
 ;;=^5001152
 ;;^UTILITY(U,$J,358.3,44935,0)
 ;;=C4A.31^^170^2241^81
 ;;^UTILITY(U,$J,358.3,44935,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44935,1,3,0)
 ;;=3^Merkle Cell CA,Nose
 ;;^UTILITY(U,$J,358.3,44935,1,4,0)
 ;;=4^C4A.31
 ;;^UTILITY(U,$J,358.3,44935,2)
 ;;=^5001145
 ;;^UTILITY(U,$J,358.3,44936,0)
 ;;=C4A.39^^170^2241^83
 ;;^UTILITY(U,$J,358.3,44936,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44936,1,3,0)
 ;;=3^Merkle Cell CA,Parts of Face,Other
 ;;^UTILITY(U,$J,358.3,44936,1,4,0)
 ;;=4^C4A.39
 ;;^UTILITY(U,$J,358.3,44936,2)
 ;;=^5001146
 ;;^UTILITY(U,$J,358.3,44937,0)
 ;;=C4A.59^^170^2241^84
 ;;^UTILITY(U,$J,358.3,44937,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44937,1,3,0)
 ;;=3^Merkle Cell CA,Parts of Trunk,Other
 ;;^UTILITY(U,$J,358.3,44937,1,4,0)
 ;;=4^C4A.59
 ;;^UTILITY(U,$J,358.3,44937,2)
 ;;=^5001150
 ;;^UTILITY(U,$J,358.3,44938,0)
 ;;=C4A.8^^170^2241^82
 ;;^UTILITY(U,$J,358.3,44938,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44938,1,3,0)
 ;;=3^Merkle Cell CA,Overlapping Sites
 ;;^UTILITY(U,$J,358.3,44938,1,4,0)
 ;;=4^C4A.8
 ;;^UTILITY(U,$J,358.3,44938,2)
 ;;=^5001157
 ;;^UTILITY(U,$J,358.3,44939,0)
 ;;=C4A.9^^170^2241^88
 ;;^UTILITY(U,$J,358.3,44939,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44939,1,3,0)
 ;;=3^Merkle Cell CA,Unspec
 ;;^UTILITY(U,$J,358.3,44939,1,4,0)
 ;;=4^C4A.9
 ;;^UTILITY(U,$J,358.3,44939,2)
 ;;=^5001158
 ;;^UTILITY(U,$J,358.3,44940,0)
 ;;=C84.09^^170^2241^93
 ;;^UTILITY(U,$J,358.3,44940,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44940,1,3,0)
 ;;=3^Mycosis Fungoides,Extranodal/Solid Organ Sites
 ;;^UTILITY(U,$J,358.3,44940,1,4,0)
 ;;=4^C84.09
 ;;^UTILITY(U,$J,358.3,44940,2)
 ;;=^5001630
 ;;^UTILITY(U,$J,358.3,44941,0)
 ;;=C84.03^^170^2241^96
 ;;^UTILITY(U,$J,358.3,44941,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44941,1,3,0)
 ;;=3^Mycosis Fungoides,Intra-Abdominal Lymph Nodes
 ;;^UTILITY(U,$J,358.3,44941,1,4,0)
 ;;=4^C84.03
 ;;^UTILITY(U,$J,358.3,44941,2)
 ;;=^5001624
 ;;^UTILITY(U,$J,358.3,44942,0)
 ;;=C84.06^^170^2241^97
 ;;^UTILITY(U,$J,358.3,44942,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44942,1,3,0)
 ;;=3^Mycosis Fungoides,Intrapelvic Lymph Nodes
 ;;^UTILITY(U,$J,358.3,44942,1,4,0)
 ;;=4^C84.06
 ;;^UTILITY(U,$J,358.3,44942,2)
 ;;=^5001627
 ;;^UTILITY(U,$J,358.3,44943,0)
 ;;=C84.02^^170^2241^98
 ;;^UTILITY(U,$J,358.3,44943,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44943,1,3,0)
 ;;=3^Mycosis Fungoides,Intrathoracic Lymph Nodes
